TORONTO, April 8, 2025 /PRNewswire/ -- MolecuLight Inc. [https://c212.net/c/link/?t=0&l=en&o=4400505-1&h=1622585491&u=https%3A%2F%2Fus.moleculight.com%2F&a=MolecuLight+Inc.], a global pioneer in point-of-care fluorescence imaging for rapid bacterial detection in wounds, announces its presence at the American Burn Association (ABA) Annual Meeting in Phoenix, AZ, April 8-11. MolecuLight will showcase its innovative fluorescence imaging systems that empower providers with immediate, non-invasive bacterial visualization for optimized burn care.
https://mma.prnewswire.com/media/2659606/MolecuLight_MolecuLight_Optimizes_Burn_Care_with_Advanced_Bacter.jpg [https://mma.prnewswire.com/media/2659606/MolecuLight_MolecuLight_Optimizes_Burn_Care_with_Advanced_Bacter.jpg]
Attendees at the ABA meeting will have the opportunity to:
-- Witness Clinical Breakthroughs - Podium Presentation: Dr. Erik
Hanson-Viana, renowned plastic and reconstructive surgeon at Hospital
Angeles in Mexico City, will present his research on "Fluorescence
Imaging-Guided Sampling Provides More Accurate and Actionable
Microbiology Compared to the Levine Technique" on Wednesday, April 9(th)
at 11:45 AM during the Educational Forums and Correlatives session. He
will unveil how MolecuLight-guided sampling revolutionizes large burn
reconstruction, enabling optimal graft timing and site selection,
surpassing traditional techniques.
-- Explore Cutting-Edge Research - Poster Presentation: Dr. Carlos Daniel
Torres García, plastic and reconstructive surgery resident at Hospital
Angeles, will present his award-winning research, "Bacterial
Fluorescence Signals Are Associated with Dermal Regeneration Template
Infections in Burn Patients", on Wednesday April 9(th) at 12:30 PM
during Poster Roud 1. This work demonstrates the critical link between
bacterial loads detected using MolecuLight and failure of cellular
tissue products in burn reconstruction. Dr. García's research has been
internationally recognized, earning 2(nd) place for Best Scientific
Protocol in the 55(th) Annual Mexican National Plastic Surgery Congress
earlier this year.
-- Hands-On Innovation - Live Demonstrations at Booth #626: MolecuLight
will exhibit at Booth #626 throughout the conference. Attendees can
engage with Dr. Erik Hanson-Viana and MolecuLight representatives, and
experience live demonstrations of the MolecuLight i:X® and MolecuLight
DX(TM) imaging systems, understanding how these technologies can provide
real-time bioburden information to guide clinical decision-making for
optimized burn care.
"The ability to visualize bacteria in real-time with MolecuLight has far-reaching implications for improving burn wound reconstruction," says Dr. Erik Hanson-Viana. "By providing immediate, actionable information, MolecuLight has led to more precise interventions, ultimately improving reconstructive outcomes. My research also demonstrates the clear advantage of MolecuLight-targeted sampling over traditional methods, and I am thrilled to share these findings with my colleagues at the ABA meeting."
About MolecuLight Inc:
MolecuLight Inc. [https://c212.net/c/link/?t=0&l=en&o=4400505-1&h=1183139763&u=http%3A%2F%2Fwww.moleculight.com%2F&a=MolecuLight+Inc.] is a privately owned medical imaging company with a global presence that manufactures and commercializes the MolecuLight i:X(®) and DX((TM)) wound imaging devices. These are the only class II FDA-cleared point-of-care imaging devices for the real-time detection of elevated bacterial burden in wounds. They also provide accurate digital wound measurement for comprehensive wound management, supported by strong clinical evidence including over 100 peer-reviewed publications [https://c212.net/c/link/?t=0&l=en&o=4400505-1&h=816655906&u=https%3A%2F%2Fmoleculight.app.box.com%2Ffile%2F1660365959569%3Fs%3D41xqtgrs69y0d6qx16kmgud90os5rnps&a=100+peer-reviewed+publications].
www.moleculight.com [https://c212.net/c/link/?t=0&l=en&o=4400505-1&h=852226297&u=https%3A%2F%2Fwww.moleculight.com&a=www.moleculight.com]
Photo - https://mma.prnewswire.com/media/2659606/MolecuLight_MolecuLight_Optimizes_Burn_Care_with_Advanced_Bacter.jpg [https://c212.net/c/link/?t=0&l=en&o=4400505-1&h=3562990714&u=https%3A%2F%2Fmma.prnewswire.com%2Fmedia%2F2659606%2FMolecuLight_MolecuLight_Optimizes_Burn_Care_with_Advanced_Bacter.jpg&a=https%3A%2F%2Fmma.prnewswire.com%2Fmedia%2F2659606%2FMolecuLight_MolecuLight_Optimizes_Burn_Care_with_Advanced_Bacter.jpg]
View original content:https://www.prnewswire.co.uk/news-releases/moleculight-optimizes-burn-care-with-advanced-bacterial-imaging-at-the-american-burn-association-2025-annual-meeting-302422559.html [https://www.prnewswire.co.uk/news-releases/moleculight-optimizes-burn-care-with-advanced-bacterial-imaging-at-the-american-burn-association-2025-annual-meeting-302422559.html]
Photo: https://mma.prnewswire.com/media/2659606/MolecuLight_MolecuLight_Optimizes_Burn_Care_with_Advanced_Bacter.jpg MolecuLight Inc.CONTACT: For sales, media or other inquiries or further information,
please contact: Danielle Dunham, Director of Product, MolecuLight Inc., T.
+1.416.542.5524, ddunham@moleculight.com
